Medison, an Israel-based global pharma company, announced on Monday that it has named Sarah Otten as its new VP, GM of Medison's Americas Region.
In the new role, Otten will lead Medison's Americas region, covering Canada and Latin America.
Otten has served as VP Global Market Access and Commercial Strategy for Apellis Pharmaceuticals. She has served in senior roles in Commercial and Corporate Compliance, including executive director Global Geographic Expansion and head of Latin America, and an additional 12 years at Pfizer, where she served in various roles in sales operations and market access.
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer